Volume 4; Issue 6

European Journal of Cancer Supplements

Volume 4; Issue 6

1

IFC: Editorial Board

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 43 KB

english, 2006

2

Author index

Journal:

European Journal of Cancer Supplements

Year:

2006

File:

PDF, 31 KB

2006

3

Src-from oncogene to clinical target

Justin M. Summy, Michael J. Gray, Gary E. Gallick

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 106 KB

english, 2006

4

AP-1-dependent gene expression during skin tumourigenesis

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

5

Enzastaurin – From bench to bedside, and back

Manfred Lehnert

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

6

Survivin and transforming growth factor beta (TGF-β) as drug targets in cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

7

Plasminogen activation and cancer: Basic mechanisms and perspectives

Keld Danø, Niels Behrendt, Gunilla Høyer-Hansen, Morten Johnsen, Leif R. Lund, Michael Ploug, Boye Schnack Nielsen, John Rømer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

8

The urokinase receptor, cell migration, proliferation and cancer

Francesco Blasi

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

9

Involvement of p38-SAPK and endoplasmic reticulum-stress signaling pathways in the induction of cancer dormancy and drug resistance

Julio A. Aguirre-Ghiso, Aparna C. Ranganathan, Lin Zhang, Alejandro P. Adam, Sharon J. Sequeira, Zoya Demidenko, Bibiana V. Iglesias, Shishir Ohja

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

10

ZNF306, a novel zinc finger transcription factor, drives colon cancer progression – An alternate genetic pathway in tumor progression?

L. Yang, S. Hamilton, E. Ellis, A.M. Sanguino, G. Lopez-Berestein, D.D. Boyd

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

11

Specific transcriptional regulators of the u-PAR gene – In vivo and clinical relevance, and first suggestions for molecular tumor staging

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

12

uPA and PAI-1: Clinically and technically validated prognostic markers in breast cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

13

Expression of markers of invasion and progression – Comparing molecular determinants with phenotypes

Rainer Grobholz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

14

Molecular mechanisms of matrix metalloproteinase (MT-MMP) induction of cancer cell migration and metastasis

Stanley Zucker, Jian Cao

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

15

Cross-analysis of gene and miRNA expression in heredo-familial breast cancers

Marco A. Pierotti

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 43 KB

english, 2006

16

Use of specialized arrays for the diagnosis of pancreatic tumours

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

17

Hierarchical neural net technology for molecular staging with clinical data

R. Kates, H. Allgayer, N. Harbeck

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

18

Bioinformatics tools for molecular cancer diagnostics on microarrays

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

19

Conventional statistical methodology in large scale profiling

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 47 KB

english, 2006

20

Molecular MRI imaging of glioblastoma models

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

21

Molecular imaging chances and challenges

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

22

Current status on molecular markers and targets in pancreatic disease

Christoph Michalski, Jörg Kleeff, Markus W. Büchler, Helmut Friess

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

23

New key markers and therapeutic subgroups in breast cancer resulting from molecular staging

N. Harbeck, R.E. Kates, C. Thomssen, M. Schmitt

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 40 KB

english, 2006

24

DNA-methylation markers and YB-1 as indicators of therapy response in breast cancer

M. Schmitt, N. Harbeck, J. Foekens, S. Maier

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

25

Molecular pathogenesis of papilloma virus associated cancers

Nicolas Wentzensen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

26

Developing strategies for tumor vaccination

Andreas Mackensen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

27

Targeting MUC1 with liposomal BLP25

Martin H. Falk, Karl-Josef Kallen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 49 KB

english, 2006

28

Survivin – Preclinical rational and preliminary results

Jürgen C. Becker, Mads Hald Andersen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

29

The role of EGFR family in preneoplasia and lung cancer; Perspectives for targeted therapies and selection of patients

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

30

Impact of epidermal growth factor receptor (EGFR) mutations on responsiveness of non-small cell lung cancer (NSCLC) to tyrosine kinase inhibitors (TKIs): Prospective observations

Nico van Zandwijk, Alexandre Mathy, Daphne de Jong, Paul Baas, Sjaak Burgers, Petra Nederlof

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

31

Anti-tumor applications of activating toll-like receptor 9 with PF-3512676 (Formerly CPG 7909)

Arthur M. Krieg

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 42 KB

english, 2006

32

Gene profiling in melanoma – What have we gained?

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 42 KB

english, 2006

33

Tumor stroma-associated antigens for anti-cancer immunotherapy

Jürgen C. Becker, Valeska Hofmeister, David Schrama

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 51 KB

english, 2006

34

Molecular phenotyping of minimal residual disease in solid cancer – Defining the markers for tumor progression?

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

35

Targeting Plk1 for cancer therapy

Mathias Schmidt, Hans-Peter Hofmann, Karl Sanders, Volker Gekeler, Thomas Beckers

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 41 KB

english, 2006

36

Regulation of UCN-01 induced mitotic cell death by pro- and anti-apoptotic pathways

Celia Vogel, Christian Hager, Holger Bastians

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 50 KB

english, 2006

37

Viral oncogenes causing human cancers

Harald zur Hausen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

38

Oncoprotective parvoviruses in cancer therapy

Jean Rommelaere

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

39

Prophylactic vaccines against cervical cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 47 KB

english, 2006

40

Identification of potential target antigens for immunotherapy approaches

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

41

T cell based immunotherapy – Changes and challenges

Volker Schirrmacher

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

42

Targeting the apoptotic pathway to induce radioresistance in normal tissue and stem cells

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 47 KB

english, 2006

43

Challenges in defining genetic risks for familial colorectal cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

44

Molecular diagnosis of hereditary colorectal cancers

Hans K. Schackert

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 38 KB

english, 2006

45

EGFR-signalling in colon cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 48 KB

english, 2006

46

Therapeutic decisions from molecular staging in colorectal cancer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

47

Anti-tumour potential of zoledronic acid (Zometa®)

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

48

Bone sialoprotein is predictive of bone metastases in resectable non small cell lung carcinoma: A case–control study and prevalence data

M. Papotti, T. Kalebic, M. Volante, E. Bacillo, S. Cappia, G.V. Scagliotti

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 43 KB

english, 2006

49

Different roles of “stem cells” in gliomas

Roland Goldbrunner, Niklas Thon, Christian Schichor

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

50

Targeted delivery of chemotherapy using microencapsulated cells for GDEPT

J.-Matthias Löhr

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 44 KB

english, 2006

51

Developing strategies for tumor vaccination

Andreas Mackensen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 44 KB

english, 2006

52

Molecular staging of thyroid cancers and associated familial syndromes – Consequences for screening and therapy

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

53

Pdcd4 targets eIF4A to inhibit translation, transcription, tumorigenesis, and invasion

Nancy H. Colburn, Hsin-Sheng Yang, Aaron Jansen

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 44 KB

english, 2006

54

Molecular Staging of Cancer – 2nd International Conference 22–26 June, 2006 – A meeting co-organized by Klinikum Mannheim, University Heidelberg and DKFZ (German Cancer Research Center) Heidelberg, Germany

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

55

Protein lysate array assessment of therapeutic targets in sarcoma

Dennis P.M. Hughes

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 74 KB

english, 2006

56

Molecular staging of NSCLC: 2006

Thomas J. Lynch Jr.

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 106 KB

english, 2006

57

siRNA-technology on the road to molecular therapy

Steven Dooley, Patrico Godoy

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

58

P1. Overexpression of the C4.4A protein, a uPAR homologue, in cancer

Claudia Paret, Jürgen Weitz, Annegret Kuhn, Jesco Pfitzenmaier, Doris Mayer, Margot Zöller

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 84 KB

english, 2006

59

P2. Downregulation of urokinase-type plasminogen activator inhibitor (PAI-1) in pancreatic cancer

R. Metzger, U. Warnecke-Eberz, K.L. Prenzel, S.E. Baldus, J. Brabender, D. Vallböhmer, A.H. Hölscher, P.M. Schneider

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 84 KB

english, 2006

60

P3. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2α-related factor binding to different regions of the urokinase receptor (u-PAR) gene in resected colorectal cancers

Denis Martin Schewe, Tobias Biller, Gabriele Maurer, Irfan A. Asangani, Joerg H. Leupold, Ernst R. Lengyel, Stefan Post, Heike Allgayer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

61

P4. Tumor suppressor Pdcd4 inhibits invasion and regulates urokinase-receptor (u-PAR) gene expression via Sp-transcription factors

J.L. Leupold, H.S. Yang, N.H. Colburn, D.D. Boyd, E.R. Lengyel, S. Post, Allgayer Heike

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

62

P5. Evidence of Pdcd 4 as a novel marker for tumor diagnosis and progression in resected colorectal carcinomas

F. Medved, R. Grobholz, C. Jost, G. Mudduluru, J.H. Leupold, J. Schumacher, N.H. Colburn, S. Post, H. Allgayer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

63

P6. Proteinases activated receptors: Expression and quantification in colon and prostate human cancer

Asmaa El Atmani, Yves Allory, Stéphane Moutereau, Jean Claude Kouyoumdjian, Philippe Manivet, Sylvain Loric

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

64

P7. Complete compilation of matrix metalloproteinase expression in human malignant gliomas

Jelena Stojic, Carsten Hagemann, Siglinde Kühnel, Stefanie Gerngras, Klaus Roosen, Giles Hamilton Vince

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

65

P8. The serine protease Bssp regulates keratinocyte proliferation and migration by modulation of E-cadherin/β-catenin signalling

Britta Klucky, Regina Mueller, Bettina Hartenstein, Kai Breuhahn, Peter Schirmacher, Jochen Hess, Peter Angel

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

66

P9. Eps8 associates with actin at the leading edge and indicates migratory potential in pancreatic cancer cell lines

T. Welsch, K. Endlich, T. Giese, A. Märten, M.W. Büchle, J. Schmidt

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

67

P10. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis

Hany Kayed, Jörg Kleeff, Shereen Keleg, Klaus Felix, Thomas Giese, Martin R. Berger, Markus W. Büchler, Helmut Friess

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

68

P11. Influence of neuroendocrine tumor differentiation on cell adhesion molecule expression in prostatic carcinoma

Ö. Cuhadaroglu, C.G. Sauer, R. Grobholz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

69

P12. Expression of MUC18 (CD146) in human choroidal melanomas

M.C. Madigan, V. Sharma, K. Lai, M.J. Jager, R.M. Conway

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

70

P13. RalA and RalB proteins contribute to metastasis stimulation through distinct pathways

V. Rybko, K. Ukraintsev, A. Martinjuk, N. Dyakova, A. Komelkov, O. Kovaleva, E. Tchevkina

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

71

P14. ADAM-17: A mediator of breast cancer progression?

Patricia McGowan, Brid Ryan, Arnold Hill, Enda McDermott, Niall O’Higgins, Michael J. Duffy

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

72

P15. Profiling of neoplasms of the pancreas using microarray-technology

Andrea Bauer, Melanie Bier, Martin Wirtz, Jörg Kleeff, Helmut Friess, Jörg D. Hoheisel

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

73

P16. Chemoresistance of pancreatic tumors – A proteome analysis

R. Faissner, A. Funk, S. Wandschneider, M. Schnölzer, J.-M. Löhr

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

74

P17. Effects of tumor–stroma interaction on global gene expression in breast cancer

Martin Buess, Dimitry S.A. Nuyten, Trevor Hastie, Patrick O. Brown

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

75

P18. Quantitative multigene expression profiling of primary prostate cancer

U. Schmidt, S. Fuessel, R. Koch, G.B. Baretton, M. Froehner, M.P. Wirth, A. Meye

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

76

P19. Gene therapeutic overexpression of MDR1 results in upregulation of further genes involved in detoxification and delivers radioprotection

Patrick Maier, Katharina Fleckenstein, Li Li, Stephanie Laufs, W. Jens Zeller, Stefan Fruehauf, Carsten Herskind, Frederik Wenz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

77

P20. TACI-signalling in multiple myeloma – From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

Jérôme Moreaux, Dirk Hose, John De Vos, Jean-François Rossi, Karène Mahtouk, Thierry Rème, Thomas Möhler, Marion Moos, Eric Jourdan, Friedrich W. Cremer, Hartmut Goldschmidt, Bernard Klein

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

78

P21. A molecular classification of multiple myeloma (MM) based on gene expression profiling and fluorescence in situ hybridisation as independent prognostic factor for event free survival (EFS)

Dirk Hose, John De Vos, Carina Ittrich, Jean-François Rossi, Thierry Rème, Axel Benner, Karène Mahtouk, Coral del Val, Agnes Hotz-Wagenblatt, Jérôme Moreaux, Sunitha Jonnakut, Marc Raab, Philine Kauke

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

79

P22. Classification of colorectal cancer – Comparison between established staging parameters and signatures based on transcript profiling

J. Gröne, B. Mann, M. Heinze, T. Brümmendorf, K. Hermann, A. Rosenthal, H.J. Buhr

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

80

P23. A new family of KIAA1245 genes with and without the HERV-K LTRs in their introns

Anna E. Illarionova, Tatyana V. Vinogradova, Pavel A. Zhulidov, Eugeny D. Sverdlov

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

81

P24. Polymorphisms of the pKi-67 promoter and their biologic relevance

M. Duchrow, D. Maaser, A. Wehrstedt, J.K. Habermann, U.J. Roblick, H.P. Bruch

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

82

P25. Matrix metalloproteinase 9 single nucleotide polymorphism analysis in blood of urological cancer patients

D. Stanciute, J. Didziapetriene, F. Jankevicius

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

83

P26. Antagonistic function of S100 proteins during tumor development

Christoffer Gebhardt, Michiel van der Sanden, Lars Hummerich, Kai Breuhahn, Julia Németh, Meinhard Hahn, Alexander Enk, Gerhard Fuerstenberger, Cornelia Mauch, Peter Schirmacher, Peter Lichter, Peter

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

84

P27. Deficient mitotic chromatin condensation in response to Chk1 inhibition is mediated by deregulated Cdc25B

Harald Löffler, Blanka Rebacz, Anthony D. Ho, Jiri Lukas, Jiri Bartek, Alwin Krämer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

85

P28. Promoter analysis of human small regulatory subunit calpain, CSS1

I.A. Asangani, J.H. Leupold, S.A.K. Rasheed, S. Gil-Parrado, S. Post, H. Allgayer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

86

P29. Multiplex Rt-Pcr detection of prostatic genes expressing cells in the blood of prostate cancer patients

Stéphane Moutereau, Carlosse Keumeugni, Asmaa El Atmani, Mihelaiti Chimingqi, Richard Douard, Michel Devanlay, Pascal Schwege, Sylvain Loric

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 55 KB

english, 2006

87

Prognostic value of prostate circulating cells detection in prostate cancer patients: A prospective study

Stéphane Moutereau, Pascal Eschwege, Zahi Aboujeili, Stéphane Droupy, Richard Douard, Jean-Luc Gala, Marc Conti, Philippe Manivet, Sylvain Loric

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

88

P31. Survivin mRNA levels in peripheral blood from patients with esophageal cancer decrease significantly following surgical resection and are influenced by neoadjuvant chemoradiation

A.-C. Hoffmann, U. Warnecke-Eberz, K. Prenzel, J. Brabender, D. Vallboehmer, R. Metzger, A.H. Hölscher, P.M. Schneider

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

89

P32. CD133 positive “Cancer stem cells” in gliomas of different grades

N. Thon, S. Grau, K. Damianoff, O. Schnell, J.C. Tonn, R. Goldbrunner

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 67 KB

english, 2006

90

P33. Expression of alpha v beta 3 integrin in patients with high and low grade glioma

O. Schnell, B. Krebs, E. Wagner, A.J. Beer, S.J. Grau, C. Goetz, H.A. Kretzschmar, R.H. Goldbrunner, J.C. Tonn

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 56 KB

english, 2006

91

P34. Expression of lymphangiogensis related VEGFR3 in malignant gliomas

S. Grau, F. Trillsch, N. Thon, O. Schnell, P. Nelson, J.-C. Tonn, R. Goldbrunner

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 56 KB

english, 2006

92

P35. Intratumoral patterns of clonal evolution in meningiomas

R. Ketter, J. Rahnenführer, W. Henn, S. Wemmert, Y.J. Kim, T. Lengauer, K.D. Zang, W.I. Steudel, S. Urbschat

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

93

P36. The calcium binding proteins S100A8 and S100A9 as novel markers for human prostate cancer

Alexander Hermani, Rainer Grobholz, Lutz Trojan, Peter Angel, Doris Mayer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

94

P37. Gd-DOTA and fluorophore substituted polyamines as intracellular contrast agents for magnetic resonance and fluorescence imaging of tumors

Markus Wolf, William E. Hull, Ulrike Bauder-Wüst, Helmut Eskerski, Rüdiger Pipkorn, Michael Eisenhut

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 57 KB

english, 2006

95

P38. The interaction of EpCAM and Claudin-7 – Structural characterization and functional relevance

Sebastian Kuhn, Markus Ladwein, Ulrich-Frank Pape, Werner W. Franke, Margot Zöller

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

96

P39. Chk1 accumulates at the centrosome in response to DNA damage

Harald Löffler, Tilmann Bochtler, Anthony D. Ho, Penny A. Jeggo, Jiri Bartek, Alwin Krämer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

97

P40. The human IIIb-mRNA splice-variant of the FGF-receptor-1(FGFR1) reduces the transforming potential of pancreatic carcinoma cell lines in vitro and in vivo

M. Thiere, Z. Liu, D. Henne-Bruns, M. Kornmann

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 63 KB

english, 2006

98

P41. Relevance of the PTEN and p27KIP1 expression in prostate cancer after short term antihormonal therapy

K. Becker, C.G. Sauer, H. Zentgraf, R. Grobholz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

99

P42. Glycogen synthase kinase 3beta (GSK3beta) as a key component of estradiol signalling pathway

Grisouard Jean, Medunjanin Senad, Strauth Stephanie, Hermani Alexander, Mayer Doris

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

100

P43. ErbB-signalling in multiple myeloma – From the identification as potential therapeutic target by gene expression analysis and functional testing to clinical trials

Karène Mahtouk, Dirk Hose, John De Vos, Ulrike Klein, Jean-François Rossi, Thierry Rème, Thomas Möhler, Jérôme Moreaux, Marion Moos, Eric Jourdan, Friedrich W. Cremer, Hartmut Goldschmidt, Bernard Kle

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 70 KB

english, 2006

101

P44. Mouse models of spontaneous melanoma as a tool for development of new immunotherapies of human melanoma

V. Umansky, O. Speicher, S. Kimpfler, A. Thölke, D. Schadendorf

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

102

P45. Protein kinase inhibitors as modifiers of radiosensitivity in glioblastoma cells

M. Wang, D. Milanovic, F. Lohr, F. Wenz, C. Herskind

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 61 KB

english, 2006

103

P46. Identification and characterization of centrosomal cluster-inhibitors as novel anti-cancer agents

Blanka Rebacz, Harald Löffler, Cihan Cetin, Rainer Pepperkok, Anthony D. Ho, Thomas O. Larsen, Alwin Krämer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 72 KB

english, 2006

104

P47. Radioprotection of normal tissue cells by transfer of the human superoxide-dismutase gene

M.R. Veldwijk, C. Herskind, S. Laufs, W.J. Zeller, S. Fruehauf, F. Wenz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

105

P48. Gonadotrophin releasing hormone based vaccine (GnRHm1-TT), an effective candidate for hormonedependent cancer immunotherapy

Jesús A. Junco, Peter Peschke, Volker Ehrman, Franklin Fuentes, Eddy Bover, Ivan Zuna, Eulogio Pimentel, Marı́a D. Castro, Roberto Basulto, Lesvia Calzada, Niurka Arteaga, Yovisleidis López, Osvaldo R

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

106

P49. Zoledronic acid has direct anti-proliferative and anti-metastatic effect on pancreatic carcinoma cells and acts as an antigen for δ2 γ/δ T cells

Angela Märten, Marie von Lilienfeld-Toal, Markus W. Büchler, Jan Schmidt

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 74 KB

english, 2006

107

P50. The tetraspanin D6.1A induces tumor angiogenesis

Sabine Gesierich, Igor Berezovskiy, Eduard Ryschich, Margot Zöller

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

108

P51. Defining the apoptotic pathways underlying histone deacetylase inhibitor-mediated tumor therapy

Ralph K. Lindemann, Andrea Newbold, Kate Whitecross, Anthony E. Dear, Clare L. Scott, Andrew Wei, Victoria Richon, Scott W. Lowe, Ricky W. Johnstone

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

109

P52. Association of DNA-repair polymorphisms with survival in lung cancer patients

H. Dally, S. Tuengerthal, P. Drings, J.R. Fischer, L. Edler, B. Jäger, O. Popanda, B. Spiegelhalder, H. Bartsch, A. Risch

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 74 KB

english, 2006

110

P53. In vitro histoculture of colorectal carcinomas as a model system for the assessment of therapeutic approaches

D. Nikolova, J.J. Cornelis, H. Weckauf, W. Fiehn, J. Rommelaere, M. Volkmann

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

111

P54. Expression alterations of molecular markers in different types of NSCLC as a significant prognostic factor

M. Kochetkova, A. Griazeva, A. Alahverdiev, L. Gurevich, E. Korsakova, E. Smirnova, I. Zborovskaya

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 72 KB

english, 2006

112

P55. In situ molecular assessment of CD8+ T cell reactivity in NSCLC

A. Trojan, M. Montemurro, R.A. Stahel, D. Jäger

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

113

P56. Upregulation of COX-2 expression occurs already in gastroesophageal reflux disease but is further increased in Barrett’s esophagus and Barrett’s cancer

G. Lurje, D. Vallboehmer, S.E. Baldus, A.H. Hoelscher, P.M. Schneider

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 62 KB

english, 2006

114

P57. Association of cyclooxygenase-2 expression with development and progression of Barrett’s metaplasia–dysplasia–carcinoma sequence and the environmental inflammatory reaction

F.C. Ling, S.E. Baldus, J. Khochfar, J. Brabender, R. Metzger, H.P. Dienes, U. Drebber, E. Bollschweiler, A.H. Hoelscher, P.M. Schneider

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 75 KB

english, 2006

115

P58. HIF-1α mRNA is significantly overexpressed in esophageal squamous cell cancer but not associated with histopathologic regression following neoadjuvant chemoradiation

F.C. Ling, N. Leimbach, S.E. Baldus, J. Brabender, R. Metzger, U. Drebber, H.P. Dienes, R.P. Mueller, A.H. Hoelscher, P.M. Schneider

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

116

P59. Towards the molecular characterization of disease: Comparison of molecular and histological analysis of esophageal epithelia

D. Vallböhmer, P. Marjoram, H. Kuramochi, S. DeMeester, P.T. Chandrasoma, K.D. Danenberg, J. Brabender, P.M. Schneider, A.H. Hölscher, T.R. DeMeester, P.V. Danenberg, J.H. Peters

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

117

P60. Hypoxia-regulated proteins in gastric cancer: Correlation with disseminated tumor cells and clinical outcome

S. Osinsky, D. Gluzman, G. Olijnichenko, L. Bubnovskaya, I. Ganusevich, D. Osinsky, S. Merentsev, L. Gumenjuk

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

118

P61. Peculiarities of gastric carcinomas in patients under 50 years of age

C. Schildberg, T. Horbach, S. Merkel, T. Papadopoulos, A. Dimmler, W. Hohenberger

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

119

P62. Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide (TEC)

U. Vogt, C.M. Schlotter, U. Bosse, U. Bonk, B.H. Brandt

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 75 KB

english, 2006

120

P63. Expression of tissue factor in pancreatic adenocarcinoma

Stephan L. Haas, Ralf Jesnowski, Michael Steiner, Frank Hummel, Jörg Ringel, Christine Burstein, Horst Nizze, Stefan Liebe, J.-Matthias Löhr

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

121

P64. Protein-bound polysaccharide PSK induces growth inhibition in pancreatic tumor cells

Ralf Jesnowski, Matthias Löhr

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

122

P65. Prediction of metastases and local tumor invasion in pancreatic cancer using an orthotopic SCID mouse model

M. Niedergethmann, F. Alves, B. Heidrich, J. Neff, C. Pilarsky, R. Grützmann, F. Willeke, S. Post, N. Gretz

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

123

P66. The thrombin receptor PAR-1 plays an important role in pancreatic cancer cell invasiveness in vitro

C. Rudroff, U. Schaefer, S. Seibold, M.M. Heiss

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 66 KB

english, 2006

124

P67. Pretherapeutical gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy and its impact on disease free survival

Marian Grade, Torsten Liersch, Sudhir Varma, Michael J. Difilippantonio, Claus Langer, Richard Simon, Thomas Ried, Heinz Becker, B. Michael Ghadimi

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 77 KB

english, 2006

125

P68. Gene expression signature of colorectal carcinogenesis

J.K. Habermann, U. Paulsen, U. Roblick, M.B. Upender, L. McShane, E.L. Korn, D. Wangsa, M. Duchrow, S. Krüger, H.-P. Bruch, G. Auer, T. Ried

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

126

P69. Ki-67 auto-antibodies in colorectal cancer patients

M. Duchrow, C. Ziems, J.K. Habermann, U.J. Roblick, H.P. Bruch

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 64 KB

english, 2006

127

P70. Transcriptional and molecular regulators of the urokinase-receptor-(u-PAR)-gene: First analysis of independent prognostic relevance in resected colorectal cancer

Gabriele D. Maurer, Joerg H. Leupold, Denis M. Schewe, Tobias Biller, Ronald E. Kates, Hans-Martin Hornung, Ulla Lau-Werner, Stefan Post, Heike Allgayer

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 76 KB

english, 2006

128

P71. Tamoxifen therapy stabilized cell membrane permeability for LDH in PBL of breast cancer patients

Jurisic Vladimir, Konjevic Gordana, Neskovic-Konstantinovic Zora, Neskovic Borka Spuzic Ivan

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

129

P72. Prediction of response to preoperative chemotherapy in locally advanced breast cancer

Juliane Hannemann, Johannes B.G. Halfwerk, Arno Velds, Claudette Loo, Emiel Rutgers, Sjoerd Rodenhuis, Marc J. van de Vijver

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 65 KB

english, 2006

130

Integration site monitoring in clinical gene therapy

Christof von Kalle

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 39 KB

english, 2006

131

Cell signaling by receptor tyrosine kinases: From basic concepts to clinical applications

Joseph Schlessinger

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 80 KB

english, 2006

132

Targeting the EGF receptor: experience and lessons

John Mendelsohn

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 46 KB

english, 2006

133

The ISEL and BR21 trials – Outcomes similar or different?

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

134

The ISEL and BR21 trials – Outcomes similar or different?

Journal:

European Journal of Cancer Supplements

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006